- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 319/16 - 1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Patent holdings for IPC class C07D 319/16
Total number of patents in this class: 69
10-year publication summary
|
4
|
6
|
6
|
8
|
11
|
5
|
6
|
4
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biosplice Therapeutics, Inc. | 166 |
9 |
| Genzyme Corporation | 1211 |
5 |
| Tianjin Chasesun Pharmaceutical Co., Ltd | 13 |
4 |
| Cadila Healthcare Limited | 323 |
3 |
| Special Product's Line S.p.A. | 6 |
3 |
| Impetis Biosciences Ltd. | 31 |
3 |
| BioMarin Pharmaceutical Inc. | 373 |
2 |
| Brown University | 628 |
2 |
| CHDI Foundation, Inc. | 108 |
2 |
| Florida Atlantic University Board of Trustees | 76 |
2 |
| Neuropore Therapies, Inc. | 38 |
2 |
| Nsab, Filial AF Neurosearch Sweden AB, Sverige | 11 |
2 |
| Janssen Pharmaceutica N.V. | 3612 |
1 |
| Wyeth LLC | 671 |
1 |
| Allergan, Inc. | 2438 |
1 |
| Massachusetts Institute of Technology | 9913 |
1 |
| Aldeyra Therapeutics, Inc. | 108 |
1 |
| Alkahest, Inc. | 101 |
1 |
| Biogen MA Inc. | 914 |
1 |
| Council of Scientific and Industrial Research | 608 |
1 |
| Other owners | 22 |